Test your knowledge of the 2019 "focused" updates to the 2014 AHA/ACC/HRS guidelines on the management of atrial fibrillation with this quick, 5-question quiz.
New evidence in several areas of treatment for atrial fibrillation (AF) prompted a "focused" update in Janaury 2019 to the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Test your knowledge of how approaches to anticoagulation have shifted with these 5 quick questions.
1. Warfarin is recommended over edoxaban in patients with AF who are eligible for new oral anticoagulants (NOACs) and do not have moderate-to-severe mitral stenosis or a mechanical heart valve.
1. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation [published ahead of print January 28, 2019]. Circulation. doi: 10.1161/CIR.0000000000000665.